资讯

The Taught Course in Oncology is a day-release modular programme designed for medically qualified candidates who intend to pursue a professional career in some aspect of clinical or medical oncology, ...
The Division of Cell and Molecular Biology studies the complex interplay of genes, proteins and biological processes that drive the development and growth of cancers. Understanding the many different ...
Our leadership teamProfessor Kristian Helin Chief Executive and President The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and ...
The Institute of Cancer Research believes that animal research is essential to understand how cancers develop and behave within a whole organism, and how to treat it effectively. We use animal studies ...
The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...
A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...
The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer. The ...
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...
The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.
We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...
An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading ...